COVID-19 Convalescent Plasma Therapy: Long-term Implications

This dataset contains de-identified patient data of 281 patients from 19 centers across the United States who were enrolled in the CONTAIN COVID-19 randomized controlled trial that ran from 4/17/2020-3/15/2021 and were re-consented to participate in the CONTAIN-EXTEND study for follow-up. The information in this dataset was used to conduct the analysis reported in the CONTAIN EXTEND manuscript published in Open Forum Infectious Disease (doi: 10.1093/ofid/ofad686) and includes demographic information, baseline history, baseline medications, baseline laboratory values, clinical status based on the WHO 11-point scale at month 12-24 after randomization.